Impact Factor
2.91
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.80
369 total citations
h5-index
23
h5 depth signal
Cited share
53.6%
118 of 220
Total citations
369
Citation footprint
Metric signal
1.44
External metric anchor
Self-citation
3.5%
13 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Australia
428
China
374
Japan
122
South Korea
84
Singapore
58
Citing Fields of Research
Oncology
441
Breast Cancer
171
Lung Cancer
162
Liver & Colon Cancer
149
Immunology
102
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,001
Articles tracked across the journal lifetime
Indexed publication set
220
118 cited publications
Last 12 months
160
13.3 publications/month
Open access share
28.1%
45 OA publications in the last year
Leading citing country
Australia
428 citing publications
Leading citing field
Oncology
441 citing publications
Latest tracked publication
18 October 2026
10 recent records available
Coverage & Indexing History
v5n1, Mar. 2009-
v5n1, Mar. 2009-
Research Focus & Classification
Indexed Subjects
Oncology
Breast Cancer
Lung Cancer
Liver & Colon Cancer
Immunology
Broad Categories
Neoplasms
Prostate Cancer
Palliative Care
Digestive Disorders
Lung Cancer
Breast Cancer
Medical Ethics
Liver & Colon Cancer
MeSH Descriptors
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1111/ajco.70214
Open DOI
Minimum 7‐Year Follow‐Up of a Prospective Phase II Trial of Preoperative S‐1 Plus Oxaliplatin Chemotherapy for Clinical Stage III Gastric Cancer
Aim: We report long‐term outcomes from a prospective Phase II trial of two cycles of preoperative S‐1 plus oxaliplatin (SOX) chemotherapy in patients with clinical Stage III gastric cancer (GC), with at least 7 years of follow‐up for all...
02
DOI 10.1111/ajco.70211
Open DOI
Efficacy and Safety of CSF1R Inhibitors for Recurrent or Unresectable Tenosynovial Giant Cell Tumor: A Systematic Review and Meta‐Analysis of Phase III Randomized Controlled Trials
Aim: Tenosynovial giant cell tumor (TGCT) is a rare, locally aggressive neoplasm driven by overexpression of colony‐stimulating factor 1 (CSF1). We performed a meta‐analysis of the efficacy and safety of CSF1 receptor inhibitors (CSF1Ri)...
03
DOI 10.1111/ajco.70213
Open DOI
Effects of Decision Support Interventions on Treatment Decision‐Making in Patients With Prostate Cancer: A Systematic Review and Network Meta‐Analysis
Purpose: To compare the effectiveness of decision support interventions on treatment decision‐making outcomes among men with prostate cancer. Methods: A systematic review of randomized controlled trials was conducted. Electronic database...
04
DOI 10.1111/ajco.70208
Open DOI
Selective Serotonin Receptor (5‐HT3) Antagonist Prescribing in Cancer Inpatients: A Retrospective Clinical Audit
Aim: Selective serotonin receptor (5‐HT3) antagonists are first‐line antiemetics for chemotherapy‐induced, radiotherapy‐induced, and post‐operative nausea and vomiting; other causes of nausea in advanced cancer warrant alternative agents...
05
DOI 10.1111/ajco.70210
Open DOI
Multifocal Glioblastoma Managed With Primary Temozolomide as a Strategy to Delay Radiation Therapy: Clinical and Radiological Outcomes
Aim: To evaluate the clinical and radiological outcomes of upfront temozolomide (TMZ) monotherapy in deferring radiotherapy for multifocal glioblastoma (GBM). Methods: We analysed 18 consecutive adult patients with newly diagnosed, multi...
06
DOI 10.1111/ajco.70177
Open DOI
CD147+ Cancer‐Associated Fibroblasts Promote PD‐L1 Expression in Hepatocellular Carcinoma via TIMP2/MMP2/IL‐6 Signaling
Background: Targeting CD147 on hepatocellular carcinoma (HCC) cells has demonstrated therapeutic efficacy. Cancer‐associated fibroblasts (CAFs) have been identified as critical components of the tumor microenvironment. The role of CD147 ...
07
DOI 10.1111/ajco.70198
Open DOI
Application of Multimodal Respiratory Training Combined With Resistance Exercise in Promoting Postoperative Recovery After Thoracoscopic Lung Cancer Resection
Objective: This study aimed to assess the effect of multimodal respiratory training combined with resistance exercise on postoperative recovery in patients undergoing thoracoscopic lung cancer resection. Methods: Seventy‐two patients wer...
08
DOI 10.1111/ajco.70207
Open DOI
Australian Practical Guide on the Management of Muscle‐Invasive Bladder Cancer
Muscle‐invasive bladder cancer presents a complex clinical challenge in Australia, where survival outcomes lag behind those in other high‐income nations. Radical cystectomy remains the most frequently used curative approach. This review ...
09
DOI 10.1111/ajco.70209
Open DOI
Comprehensive Pan‐Cancer Analysis Identifies LINC00942 as a Multifunctional lncRNA Involved in Tumor Progression, Immune Regulation, and Chemoresistance
Background: This study aimed to investigate the expression patterns, immunological functions, and prognostic value of LINC00942 across multiple cancer types, and to further examine its role in chemoresistance. Methods: LINC00942 expressi...
10
DOI 10.1111/ajco.70201
Open DOI
Molecular Subtypes of Hepatocellular Carcinoma Defined by Anesthesia‐Related Drug Target Genes During the Perioperative Period and Their Prognosis, Immunological Characteristics, and Drug Response
Background: The use of perioperative anesthetic drugs may influence the prognosis of cancer patients, but the expression characteristics and clinical significance of their associated target genes in hepatocellular carcinoma (HCC) remain ...
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
Endorsed by the Chinese Society of Clinical Oncology, the Clinical Oncological Society of Australia, and the Singapore Society of Oncology.